P

Peijia Medical Ltd
HKEX:9996

Watchlist Manager
Peijia Medical Ltd
HKEX:9996
Watchlist
Price: 5.8 HKD 0.87% Market Closed
Market Cap: 3.9B HKD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
-3%
Operating Income
Forecast
+32%
Net Income
Forecast
+156%

Wall Street
Price Targets

Price Targets Summary
Peijia Medical Ltd

Wall Street analysts forecast Peijia Medical Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Peijia Medical Ltd is 6.18 HKD with a low forecast of 4.24 HKD and a high forecast of 7.88 HKD.

Lowest Forecast
Wall Street Target
4.24 HKD
27% Downside
Average Forecast
Wall Street Target
6.18 HKD
7% Upside
Highest Forecast
Wall Street Target
7.88 HKD
36% Upside
Lowest
Price Target
4.24 HKD
27% Downside
Average
Price Target
6.18 HKD
7% Upside
Highest
Price Target
7.88 HKD
36% Upside
Peijia Medical Ltd Competitors:
Price Targets
M
301363
Mehow Innovative Ltd
57% Upside
COH
Cochlear Ltd
10% Upside
PDEX
Pro-Dex Inc
19% Upside
ALKLH
Klea Holding
191% Upside
M
301363
Mehow Innovative Ltd
57% Upside
COH
Cochlear Ltd
10% Upside
PDEX
Pro-Dex Inc
19% Upside
ALKLH
Klea Holding
191% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
1% Upside
R
228850
Rayence Co Ltd
22% Upside
4595
Mizuho Medy Co Ltd
38% Downside

Revenue
Forecast

Revenue Estimate
Peijia Medical Ltd

For the last 5 years the compound annual growth rate for Peijia Medical Ltd's revenue is 101%. The projected CAGR for the next 3 years is 31%.

101%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Peijia Medical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Peijia Medical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Peijia Medical Ltd's stock price target?
Price Target
6.18 HKD

According to Wall Street analysts, the average 1-year price target for Peijia Medical Ltd is 6.18 HKD with a low forecast of 4.24 HKD and a high forecast of 7.88 HKD.

What is Peijia Medical Ltd's Revenue forecast?
Projected CAGR
31%

For the last 5 years the compound annual growth rate for Peijia Medical Ltd's revenue is 101%. The projected CAGR for the next 3 years is 31%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.